13-100368479-G-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000282.4(PCCA):​c.1651G>T​(p.Val551Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00865 in 1,565,676 control chromosomes in the GnomAD database, including 74 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V551I) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0070 ( 4 hom., cov: 31)
Exomes 𝑓: 0.0088 ( 70 hom. )

Consequence

PCCA
NM_000282.4 missense

Scores

2
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:7O:1

Conservation

PhyloP100: -0.163

Publications

16 publications found
Variant links:
Genes affected
PCCA (HGNC:8653): (propionyl-CoA carboxylase subunit alpha) The protein encoded by this gene is the alpha subunit of the heterodimeric mitochondrial enzyme Propionyl-CoA carboxylase. PCCA encodes the biotin-binding region of this enzyme. Mutations in either PCCA or PCCB (encoding the beta subunit) lead to an enzyme deficiency resulting in propionic acidemia. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2010]
PCCA Gene-Disease associations (from GenCC):
  • propionic acidemia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0050973594).
BP6
Variant 13-100368479-G-T is Benign according to our data. Variant chr13-100368479-G-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 38865.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00697 (1058/151756) while in subpopulation AMR AF = 0.0128 (194/15184). AF 95% confidence interval is 0.0113. There are 4 homozygotes in GnomAd4. There are 548 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000282.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCCA
NM_000282.4
MANE Select
c.1651G>Tp.Val551Phe
missense
Exon 19 of 24NP_000273.2
PCCA
NM_001352605.2
c.1651G>Tp.Val551Phe
missense
Exon 19 of 23NP_001339534.1
PCCA
NM_001127692.3
c.1573G>Tp.Val525Phe
missense
Exon 18 of 23NP_001121164.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCCA
ENST00000376285.6
TSL:1 MANE Select
c.1651G>Tp.Val551Phe
missense
Exon 19 of 24ENSP00000365462.1
PCCA
ENST00000376286.8
TSL:2
c.1573G>Tp.Val525Phe
missense
Exon 18 of 23ENSP00000365463.4
PCCA
ENST00000376279.7
TSL:2
c.1651G>Tp.Val551Phe
missense
Exon 19 of 23ENSP00000365456.3

Frequencies

GnomAD3 genomes
AF:
0.00698
AC:
1059
AN:
151638
Hom.:
4
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00191
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0128
Gnomad ASJ
AF:
0.0110
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00519
Gnomad FIN
AF:
0.00229
Gnomad MID
AF:
0.0446
Gnomad NFE
AF:
0.00959
Gnomad OTH
AF:
0.0159
GnomAD2 exomes
AF:
0.00799
AC:
2006
AN:
250938
AF XY:
0.00856
show subpopulations
Gnomad AFR exome
AF:
0.00179
Gnomad AMR exome
AF:
0.00826
Gnomad ASJ exome
AF:
0.00924
Gnomad EAS exome
AF:
0.0000546
Gnomad FIN exome
AF:
0.00222
Gnomad NFE exome
AF:
0.0113
Gnomad OTH exome
AF:
0.0101
GnomAD4 exome
AF:
0.00883
AC:
12482
AN:
1413920
Hom.:
70
Cov.:
27
AF XY:
0.00896
AC XY:
6331
AN XY:
706318
show subpopulations
African (AFR)
AF:
0.00198
AC:
64
AN:
32402
American (AMR)
AF:
0.00805
AC:
359
AN:
44586
Ashkenazi Jewish (ASJ)
AF:
0.0100
AC:
259
AN:
25834
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39308
South Asian (SAS)
AF:
0.00682
AC:
579
AN:
84840
European-Finnish (FIN)
AF:
0.00272
AC:
145
AN:
53366
Middle Eastern (MID)
AF:
0.0362
AC:
205
AN:
5656
European-Non Finnish (NFE)
AF:
0.00963
AC:
10298
AN:
1069270
Other (OTH)
AF:
0.00977
AC:
573
AN:
58658
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
519
1037
1556
2074
2593
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
352
704
1056
1408
1760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00697
AC:
1058
AN:
151756
Hom.:
4
Cov.:
31
AF XY:
0.00739
AC XY:
548
AN XY:
74150
show subpopulations
African (AFR)
AF:
0.00191
AC:
79
AN:
41380
American (AMR)
AF:
0.0128
AC:
194
AN:
15184
Ashkenazi Jewish (ASJ)
AF:
0.0110
AC:
38
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5136
South Asian (SAS)
AF:
0.00540
AC:
26
AN:
4814
European-Finnish (FIN)
AF:
0.00229
AC:
24
AN:
10482
Middle Eastern (MID)
AF:
0.0411
AC:
12
AN:
292
European-Non Finnish (NFE)
AF:
0.00959
AC:
652
AN:
67984
Other (OTH)
AF:
0.0157
AC:
33
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
50
100
149
199
249
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00869
Hom.:
14
Bravo
AF:
0.00745
TwinsUK
AF:
0.00944
AC:
35
ALSPAC
AF:
0.0104
AC:
40
ESP6500AA
AF:
0.00227
AC:
10
ESP6500EA
AF:
0.00802
AC:
69
ExAC
AF:
0.00769
AC:
934
EpiCase
AF:
0.0144
EpiControl
AF:
0.0144

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:7Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Propionic acidemia Uncertain:1Benign:4Other:1
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

May 18, 2021
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Sep 07, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not specified Benign:2
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 18, 2022
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PCCA: BP4, BS2

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.096
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Uncertain
-0.080
CADD
Benign
5.4
DANN
Benign
0.59
DEOGEN2
Benign
0.41
T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.26
N
LIST_S2
Benign
0.69
T
MetaRNN
Benign
0.0051
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
1.2
L
PhyloP100
-0.16
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-1.2
N
REVEL
Uncertain
0.49
Sift
Benign
0.51
T
Sift4G
Benign
0.71
T
Polyphen
0.072
B
Vest4
0.25
MVP
0.24
MPC
0.19
ClinPred
0.0026
T
GERP RS
-1.8
PromoterAI
0.0057
Neutral
Varity_R
0.10
gMVP
0.54
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61749895; hg19: chr13-101020733; API